A blockbuster international deal announced Wednesday, in which New Jersey-based health products giant Johnson & Johnson has agreed to buy medical device maker Synthes for $21.3 billion, could have a ...

NEW BRUNSWICK — Johnson & Johnson agreed to buy Synthes Inc. for $21.3 billion, adding devices to treat bone fractures and trauma in the biggest purchase in the company's 125-year history. Synthes ...

For five years, DU alum Gary Doan (BS ’19, MS ’21) has helped doctors fine-tune surgeries with the use of robotics. As a ...

EAST GOSHEN – U.S. regulators warned Swiss medical device maker Synthes Inc. about violations at its Brandywine plant on Goshen Parkway and said the company may have to pay a fine if it fails to fix ...

Four top executives with West Chester, PA-based Synthes Inc. were indicted by the US Attorney for the Eastern District of Pennsylvania on charges that the company improperly engaged in off-label ...

ZURICH/NEW YORK (Reuters) - Johnson & Johnson will buy Swiss medical devices maker Synthes Inc for $21.67 billion, placing a big bet on growing its orthopedics business with one of the largest deals ...

TRENTON, N.J. — Healthcare giant Johnson & Johnson said that it will complete its $19.7 billion purchase of Synthes today — a deal J&J hopes will give it a dominant position in the growing orthopedic ...

PHILADELPHIA -- A Swiss company with major operations in West Chester, Pa., illegally tested its bone cement on about 200 people, three of whom died, according to a 52-count indictment issued Tuesday, ...

Please provide your email address to receive an email when new articles are posted on . Synthes, Inc. announced that it has acquired The Anspach Effort, Inc., a global company in the high-speed ...

The sentencing of three of the four ex-directors of medical device manufacturer Synthes to terms ranging from five to nine months over the unauthorized use of bone cement in spinal surgery clinical ...

Fourth Synthes Executive Pleads Guilty to Illegal Clinical Trials A fourth executive from West Chester, Pa.-based Synthes pleaded guilty to charges originating with illegal clinical trials the company ...

ZURICH (Reuters) - Swiss medical device maker Synthes posted a 24 percent rise in net profit to $348.8 million in the first-half of the year as high demand across all regions and product lines boosted ...